Patients with multiple sclerosis (PwMS) have a high level of fatigue and a reduced quality of
life (QoL) due to the impact of multiple sclerosis (MS). Virtual reality-based therapy (VRBT) is …

Background Sexual function is often impaired following neurological disorders such as
multiple sclerosis (MS). Young women with MS encourage disruptions in sexual function …

Background Today, it is estimated that around 5% of multiple sclerosis (MS) patients are in
the late-onset category (age at disease onset≥ 50). Diagnosis and treatment in this group …

Multiple sclerosis (MS) is a chronic and demyelinating disease with an autoimmune origin,
which leads to neurodegeneration and progressive disability. Approximately 30 to 50% of …

Background While potential risk factors for multiple sclerosis (MS) have been extensively
researched, it remains unclear how persons with MS theorize about their MS. Such theories …

Background Multiple sclerosis (MS) shares clinical/radiological features with several
monogenic diseases that can mimic MS. Objective We aimed to determine if exome …

Abstract Background Multiple Sclerosis (MS) may cluster in families, an entity known as
familial MS (FMS), possibly due to aggregation of genetic and environmental factors …

Background Limited data have been published about the epidemiology of familial multiple
sclerosis (FMS) and its comparison to the sporadic form. Additionally, the epidemiology of …

Objective To assess axonal and neuronal damage of the retina in patients with familial (fMS)
and sporadic multiple sclerosis (sMS). Methods 87 relapsing-remitting MS patients (45 …

Cladribine (CLD) treats multiple sclerosis (MS) by selectively and transiently depleting B and
T cells with a secondary long-term reconstruction of the immune system. This study provides …